![]() |
Should Medicare be allowed to negotiate drug prices?
Seeing a new add sponsored by PhRMA stating that allowing Medicare to negotiate drug prices will reduce availability of drugs. I think that might be a fib but wonder what others think. I know drug prices are very high for many Tier 4 and 5 drugs when on Medicare.
S.99 - Medicare Drug Price Negotiation Act 116th Congress (2019-2020) |
Someone needs to!
|
Not likely....too big....too influential.....too much $$$$....
|
It is disgraceful that big pharma lobbyists are able to buy enough people in DC to make us pay the highest drug prices in the world.
|
Not on Medicare yet.
Something needs to be done about pricing. Doctor presribed two heart medcines to me one of which is Eliquis(can not miss their TV adds) and three months supply was $1300. Could buy it through Canada at 1/3 the cost, but had to be ordered. Shopped around and all regular US pharmacies were very close in price. Was told by my insuror that I had to pay full price since I did not match my deductible Another drug was $1800 for 3 months. Canadian price is 1/3 of that cost. Pharmacist at Publix gave me information on coupons and saved at least 50%. Now some of us(under 65) need to clip coupons to get reasonalbe priced prescriptions. Have always said insurance is good until you become sick. |
I find it amusing that the Government is the reason on for high prices, and now people want the Government to reduce the prices.
|
Quote:
And we stupidly keep reelecting the same people. |
Quote:
another called Jublia, both of which are ridiculously expensive if you're on Medicare and in the donut whole. |
Quote:
|
1 Attachment(s)
Quote:
Quote:
You need to look at not just the cost of the medication but the overall result of paying your 25% on the big picture. I might also add that Jublia is a not covered medication in some Medicare plans as it has a very low complete cure rate, only about 10 to 15% better than placebo when using it every day for an entire year on nails where only a maximum of 50% of the nail was involved, the easier cases to cure. [see also table 2 in the link from the package insert] It did slightly better [additional 5%] if you define cure as mostly better. So if you are self paying, you may want to balance the cost against the likelihood of benefit. Photo from the manufacturer's website: |
Quote:
|
OP, Can you ask your doctor if there is a less expensive, but as effective, alternative?
|
Quote:
|
Quote:
|
1 Attachment(s)
I support Medicare being allowed to negotiate prices. But the proposals being suggested which despite overwhelming public support, may still not have enough Congressional support are weak tea. They are only suggesting negotiating for a very narrow number of medications.
I did try to find out my Senator's opinions on Medicare negotiating drug costs. I will remove the names to avoid the prohibition about political postings From 2016 [last time I can find something from this Senator] Quote:
|
Quote:
|
Quote:
Generic Eliquis was actually approved by our FDA, but because of the patent it cannot be sold here. The patent on the medication expires in 2026, that is the actual ingredient. But the patent on the manufacture of the drug lasts until 2031 in the US |
Quote:
|
According to H.R. 3, the Sec. of HHS would be allowed to negotiate rates on at least 50 brand name drugs per year without generic competitors. These rates would then also be available to commercial insurers.
One of the major reasons why drugs are so expensive is R&D. The drug sector is second only to the tech sector in R&D costs as a percentage of revenue. Restricting that revenue can stifle innovation if the drug makers know they won't get their money back which can, in fact, result in shortages if the drug maker restricts the amount they produce in response to losing money. I'm not defending the drug makers, just pointing out that, like any other business, they could scale back in response to decreased revenue. |
Quote:
|
Quote:
But if they'd just stop spending all that money lobbying, they'd profit AND be able to keep their prices down, at the same time. Also, I am against medicare being able to negotiate prices. The lower the price to medicare recipients, the higher the price for everyone else. MOST Americans don't qualify for Medicare, because MOST Americans are under 65 years of age. The prices for drugs are through the roof in all sectors, people are rationing their meds, not taking as many, or taking lower doses than their doctor says they need, just to make their prescription last until they can afford a refill. This phenomenon isn't exclusive to senior citizens. But if seniors get a break on the price, you can BET those Rx companies will make up that loss by raising the prices to everyone else. What we need to do is - yup - that really bad evil horrible concept - socialized medicine. Which is what Medicare is anyway, but the word creates a knee-jerk reaction and trigger to some folks I guess. The COUNTRY needs to negotiate prices with the pharmaceutical companies. The COUNTRY needs to mandate that insurance companies allow their insured members to get their meds from Canada, Mexico, and India (where many of their generics are manufactured). This needs to be done on a national level, not just from one company to another, or one segment of the population to another. |
Quote:
|
Eliquis in the USA will cost you about $1400 for 180 (2.5 mg) tablets. It’s manufactured by Pfizer
In Canada the Eliquis will cost you $481 for 180 (2.5 mg) tablets. This is Eliquis marketed by Bristol Myers and is NOT a generic. Bristol Myers and Pfizer have a comarketing agreement in Canada for Eliquis and is marketing Pfizer’s Eliquis. So the nongeneric prescription for Eliquis that cost you $1400 in the USA will cost you only $481 in Canada. US consumers are paying for the drug development costs … and the rest of the world is getting a free ride. Why should Medicare or any US consumer not be able to access Canadian pricing for Pfizer’s Eliquis? |
Quote:
|
Quote:
|
Quote:
The Rx industry is no different from any other profit-making industry when it comes to pricing. They set the MSRP for their product. They can negotiate lower prices, they can run specials and deals, they can offer coupons and discounts, but their MSRP is their MSRP, take it or leave it. Just like the MSRP for your car is what it is, it's set by the manufacturer. The dealer you buy your car from might have incentives to lower their asking price, but if they don't, then the price on the sticker is the price dictated by the manufacturer. Same as the can of beans on the shelf. If the store has a BOGO price, it's because the store has worked out a deal with Bush Beans for that week. The store isn't just being generous, or got too much and trying to get rid of overstock. Rx is no different. They set their MSRP, and if you have insurance, you might get a discounted price. Or you can try GoodRx or any of the other discount programs. Or - you can write to the pharmaceutical company and ask for a discount. You can usually get coupons if you ask them. This is just how it is when you live in a country that promotes capitalism above all else. It has its benefits - to those who can afford to enjoy those benefits. For everyone else, not so much. |
Politicians are corrupt
Quote:
|
Half the money they take in on sales goes goes straight back to MSM….. talk about a vicious cycle….
|
Late in the Clinton administration (1999), the government passed legislation prohibiting itself from negotiating prescription drug prices for Medicare. An obvious kowtow to the drug industry. This explains why up until recently I’ve been paying $255 for a vial of insulin under Medicare but chose to buy it in Canada for $35. Buying outside of the Medicare system saved me $4,500 a year. HR 4680 Medicare RX 2000 Act, Section 201.
|
We don't vote for competence, we vote to hear our opinions parroted.
. |
Quote:
who may not understand all the implications. I really wonder about that when I see adds for drugs like Humira or Eliquis. Access Denied |
No one can "lower drug prices". But it is possible to change who pays the most and the least. I have an idea, let's require drug companies to sell to US consumers at their lowest world wide price. So if a drug is $1 a dose in Canada, that's what they have to sell it for here. Of course, someone else has already thought of that and tried...
|
The pharmaceutical industry's argument against allowing negotiation is that lower prices will lead to less research and development and therefore fewer breakthrough, life saving drugs.
The truth is that we Americans are paying for the full cost of R&D and most other countries are only paying the marginal costs of actually producing the drug. The best and simplest answer is for the US to allow re importation of medications creating a "world price" and spreading R&D costs to all customers. |
????
OrangeBlossomBaby, Insurance companies are not restricting importation of drugs, the FDA does not allow it. |
Quote:
|
Ohiobuckeye
Quote:
|
Quote:
|
Quote:
I remember a few years ago when the price of generic Doxycycline went up from $20 a month to $260. In a week. Is that because it got more expensive to produce? No, it’s because there had been several generic drug companies making it, but when some stopped, the sole remaining maker took advantage of us by raising the prices. If the drugs are only 1/3 the price in Canada, that’s because that is the nationwide price negotiated by the Canadian government. It’s not being sold for less than the cost of making it or less than a healthy profit margin. If our legislators on both sides of the aisle refuse to do the same for us because they have been purchased by Big Pharma, they are giving a giant middle finger to all voters. They are saying, “We don’t care if you are paying $1300 a month for this medication that costs $100 to make. You don’t really matter to us. Our job is to keep drug companies happy.” As for hospitals and pharmacies, remember that they mark up the price of drugs they sell. A 20% markup on a drug costing us $100 a month makes them $20 profit, while if it costs $10 a month, they make only $2. So of course they want the cost high, whether or not they admit it. Their profits are more important to them than your pockets. Remember, this proposal came from President Trump a couple years ago, and President Biden is simply carrying on the good fight that couldn’t be won in a year. We should ALL get on board and pressure Congress to put WE THE PEOPLE above the drug companies. Like most pharmacies, Medicare has a “formulary” of drugs approved because they work well and don’t cost much. They urge that these be prescribed and prefer that doctors not prescribe drugs that cost much more but don’t work any better. For example, my blood pressure is normal because I take two generic drugs that together cost about $5 a month. If I insisted on taking the latest blood pressure med advertised on TV that costs $500 a month (maybe with a big co-payment I have to pay), maybe my doctor will prescribe it after telling me it’s a waste of money for me, but my blood pressure will still be normal. So yes, maybe Medicare will point you toward cheaper drugs that work just as well. That saves you money and saves all of us money as we pay for the cost of health insurance. So don’t be swayed by the arguments of drug companies. They only care for your money, not for you. |
Quote:
|
Years ago the owner of a pharmacy that was delivering oxygen to my father said that he would sell it at a lower price but Medicare set the price (much higher) he had to sell it for.
My assumption is higher prices in the US do help fund research but why should a citizen in the US have to pay more than a citizen in another country? And that foreign country citizen could have better financial resources the US citizen. I did have contracts with the US government and they required that I sold to them at the lowest price I offered to all customers. |
All times are GMT -5. The time now is 12:03 PM. |
Powered by vBulletin® Version 3.8.11
Copyright ©2000 - 2025, vBulletin Solutions Inc.
Search Engine Optimisation provided by
DragonByte SEO v2.0.32 (Pro) -
vBulletin Mods & Addons Copyright © 2025 DragonByte Technologies Ltd.